Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula

Infant Term Birth Clinical Trial

Official title: Acceptability of "High Sn-2" Infant Formula in Non-Breast Fed Healthy Term Infants Regarding Gastrointestinal Tolerability by Both Parents and Pediatrician. An Open Label Pilot Study Evaluation in the Gulf Cooperation Council (GCC) Countries.

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the effects of term infant formula containing high 2-palmitic vegetable oil on stool composition, stool characteristics and gastrointestinal (GI) Tolerance.

Clinical Trial Description

This is a multicenter, open label, observation study; 500 formula fed infants are planned to be enrolled from a network of general pediatricians in the Gulf countries (UAE, Kuwait, Qatar, and KSA). Eligible infants will consume a high sn-2 palmitate infant formula for 12 weeks. All enrolled infants will be evaluated at enrollment and at 4 weeks and 12 weeks. ;

Related Conditions & MeSH terms

• Infant Term Birth

• NCT number: NCT02598817
• Study type: Observational
• Source: Société des Produits Nestlé (SPN)
• Status: Completed
• Start date: July 1, 2018
• Completion date: January 5, 2021